Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus N, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark.
Acta Oncol. 2023 Jan;62(1):1-7. doi: 10.1080/0284186X.2023.2172687. Epub 2023 Jan 30.
Lung cancer is the leading cause of cancer-related death in all Nordic countries which, though similar in demographics and healthcare systems, have noticeable differences in lung cancer survival. Historically, Denmark and Finland have had higher lung cancer incidences and lower survival than Norway and Sweden. All four countries have national cancer registries. Data in these registries are often compared, but their full potential as a source of learning across the Nordic countries is impeded by differences between the registries. In this paper, we describe and compare the Nordic registries on lung cancer-specific data and discuss how a more harmonized registration practice could increase their usefulness as a source for mutual learning and quality improvements.
We describe and compare the characteristics of data on lung cancer cases from registries in Denmark, Finland, Norway and Sweden. Moreover, we compare the results from the latest annual reports and specify how data may be acquired from the registries for research.
Denmark has a separate clinical lung cancer registry with more detailed data than the other Nordic countries. Finland and Norway report lung cancer survival as relative survival, whereas Denmark and Sweden report overall survival. The Danish Lung Cancer Registry and the Swedish Cancer Registry do not receive data from the Cause of Death registries in contrast to the Finnish Cancer Registry and the Cancer Registry of Norway.
The lung cancer registries in Denmark, Finland, Norway and Sweden have high level of completeness. However, several important differences between the registries may bias comparative analyses.
肺癌是所有北欧国家癌症相关死亡的主要原因,这些国家在人口统计学和医疗体系方面相似,但肺癌生存率存在显著差异。历史上,丹麦和芬兰的肺癌发病率较高,生存率较低,而挪威和瑞典则相反。这四个国家都有国家癌症登记处。这些登记处的数据经常被比较,但由于登记处之间的差异,它们作为北欧国家学习来源的全部潜力受到了阻碍。在本文中,我们描述和比较了北欧国家关于肺癌特定数据的登记处,并讨论了如何通过更加协调的登记实践来提高它们作为相互学习和质量改进来源的有用性。
我们描述和比较了丹麦、芬兰、挪威和瑞典登记处肺癌病例数据的特征。此外,我们还比较了最新年度报告的结果,并说明了如何从登记处获取数据进行研究。
丹麦有一个单独的临床肺癌登记处,其数据比其他北欧国家更详细。芬兰和挪威报告肺癌的生存情况为相对生存率,而丹麦和瑞典报告总生存率。与芬兰癌症登记处和挪威癌症登记处不同,丹麦肺癌登记处和瑞典癌症登记处不从死因登记处获取数据。
丹麦、芬兰、挪威和瑞典的肺癌登记处具有较高的完整性。然而,登记处之间的一些重要差异可能会影响比较分析。